NUBEQA 300 mg, comprimé pelliculé — 7 plaquette(s) PVC-Aluminium de 16 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930203545
  • CIP7 3020354
  • CIS 62384935
  • Registration number EU/1/20/1432

What the source publishes

Holder
BAYER AG (ALLEMAGNE)
Active ingredients
DAROLUTAMIDE
Form
comprimé pelliculé
Package
7 plaquette(s) PVC-Aluminium de 16 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription initiale hospitalière annuelle ; prescription initiale réservée à certains spécialistes ; liste I ; renouvellement non restreint ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2020-03-27
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930203545
{
  "cis": "62384935",
  "cip7": "3020354",
  "form": "comprimé pelliculé",
  "name": "NUBEQA 300 mg, comprimé pelliculé — 7 plaquette(s) PVC-Aluminium de 16 comprimé(s)",
  "cip13": "3400930203545",
  "holder": "BAYER AG (ALLEMAGNE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "BAYER AG (ALLEMAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "3023.33",
  "authorisedOn": "2020-03-27",
  "compositions": [
    {
      "name": "DAROLUTAMIDE",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "1",
      "substanceCode": "24625",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription initiale hospitalière annuelle ; prescription initiale réservée à certains spécialistes ; liste I ; renouvellement non restreint ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "3022.31",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "NUBEQA 300 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "7 plaquette(s) PVC-Aluminium de 16 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2021-03-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DAROLUTAMIDE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription initiale hospitalière annuelle",
    "prescription initiale réservée à certains spécialistes",
    "liste I",
    "renouvellement non restreint",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/20/1432",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930203545"